InGell Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
M&A
InGell General Information
Description
Manufacturer of polymer-based injectable hydrogels intended for drug delivery. The company's custom-engineered injectable drug depots are created using water-borne, bioabsorbable polymers which can be mixed with drug compounds or other therapeutic compounds, providing the optimal release profile for the active pharmaceutical ingredient being used.
Contact Information
Website
www.ingellpharma.comCorporate Office
- L.J. Zielstraweg 1
- 9713 GX Groningen
- Netherlands
Corporate Office
- L.J. Zielstraweg 1
- 9713 GX Groningen
- Netherlands
InGell Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 01-Dec-2017 | Completed | Generating Revenue | |||
| 2. Corporate | 01-Jan-2015 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Jan-2010 | Completed | Generating Revenue |
InGell Patents
InGell Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2016349415-A1 | Compositions comprising triblock copolymers | Active | 04-Nov-2015 | ||
| AU-2016349415-B2 | Compositions comprising triblock copolymers | Active | 04-Nov-2015 | ||
| CA-3003768-A1 | Compositions comprising triblock copolymers | Active | 04-Nov-2015 | ||
| EP-3370789-A1 | Compositions comprising triblock copolymers | Active | 04-Nov-2015 | ||
| EP-3370789-B1 | Compositions comprising triblock copolymers | Active | 04-Nov-2015 | C08L71/02 |
InGell Signals
InGell Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Branching Tree | Venture Capital | Minority | ||
| GJ Smid Fonds | Venture Capital | Minority | ||
| PolyVation | Corporation | Minority | ||
| RUG Ventures | Venture Capital | Minority |
InGell FAQs
-
When was InGell founded?
InGell was founded in 2010.
-
Where is InGell headquartered?
InGell is headquartered in Groningen, Netherlands.
-
What is the size of InGell?
InGell has 5 total employees.
-
What industry is InGell in?
InGell’s primary industry is Drug Delivery.
-
Is InGell a private or public company?
InGell is a Private company.
-
What is InGell’s current revenue?
The current revenue for InGell is .
-
Who are InGell’s investors?
Branching Tree, GJ Smid Fonds, PolyVation, and RUG Ventures have invested in InGell.
-
When was InGell acquired?
InGell was acquired on 01-Dec-2017.
-
Who acquired InGell?
InGell was acquired by InnoCore Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process